SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel

Background: Vaccine-induced SARS-CoV-2-anti-spike antibody (anti-S/RBD) titers are often used as a marker of immune protection and to anticipate the risk of breakthrough infections, although no clear cut-off is available. We describe the incidence of SARS-CoV-2 vaccine breakthrough infections in COV...

Full description

Bibliographic Details
Main Authors: Annapaola Santoro, Andrea Capri, Daniele Petrone, Francesca Colavita, Silvia Meschi, Giulia Matusali, Klizia Mizzoni, Stefania Notari, Chiara Agrati, Delia Goletti, Patrizio Pezzotti, Vincenzo Puro
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Biomedicines
Subjects:
SARS-CoV-2
mRNA vaccine against SARS-CoV-2
COVID-19
breakthrough infections
immune response
Online Access:https://www.mdpi.com/2227-9059/11/5/1247

Internet

https://www.mdpi.com/2227-9059/11/5/1247

Similar Items